Danaher stock: Microsoft partnership targets connected AI labs
Published on 11/20/2026 at 16:13 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSDanaher's connected laboratory strategy
- Danaher and Microsoft are developing a common agentic platform for instrument control and scientific insight.
- MetaXpress Acquire AI Assistant is among the first commercial applications planned for customers this year.
- Additional agent-enabled instruments using the platform are planned for 2027.
Danaher and Microsoft announced a strategic partnership on Friday, November 20, to develop connected scientific instruments and an agentic platform for laboratory workflows. The announcement was carried by KXAN from a Danaher Corporation release.
The companies are working on a common platform intended to connect instruments, data and laboratory workflows. Microsoft Azure will provide the cloud infrastructure, while Microsoft Foundry will power AI agents that interpret results and guide instrument control.
Commercial applications move closer
Danaher said the first commercial applications will reach customers this year. They include MetaXpress Acquire AI Assistant from Molecular Devices, which is designed to support users of high-content cellular imaging systems.
Additional next-generation instruments using the platform are planned for 2027. The partnership is designed to let specialized products share a common foundation while remaining open to digital solutions from other laboratory suppliers.
AI targets laboratory execution
The planned applications cover experimental planning, instrument setup, guided execution, real-time quality checks and recommendations for corrective actions or follow-up experiments. Danaher said these functions will operate with user oversight and within defined safety boundaries.
In preliminary internal testing cited in the release, novice scientists using an AI-assisted Leica microscope experiment took up to 83% less time and used up to 68% fewer steps than novices working without the assistant. The company said the tests produced high-quality data and completion times comparable to those of experts.
Danaher stock traded at 205.65 euros on Lang & Schwarz at 16:04 CET on Friday, November 20.
Danaher Corporation
- ISIN: US2358511028
- Ticker: DHR
- Trading venue: Lang & Schwarz
- Price: 205.65 euros at 16:04 CET on Friday, November 20, 2026
Current market reports are available in the market reports.
More developments in Danaher's life-sciences and diagnostics portfolio are collected under More news and analyses on Danaher stock.
